Survey of Ophthalmology
Volume 47 , Pages S34-S40 , August 2002

The Hydrolysis of Bimatoprost in Corneal Tissue Generates a Potent Prostanoid FP Receptor Agonist

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Cayman Chemical Company provided 100% of the funding for this article. Kirk M. Maxey, MD, is a paid consultant for Pharmacia, the manufacturer of Xalatan. The authors are employees of Cayman Chemical, which makes and sells bimatoprost, latanoprost, unoprostone, and other PGs as research reagents.

PII: S0039-6257(02)00323-5

Survey of Ophthalmology
Volume 47 , Pages S34-S40 , August 2002